uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Neoatricon
Authorised
Human
Details
EMA number
EMEA/H/C/006044
ATC code
C01CA04
Authorisation
27 May 2024
Revision
1
EMA page
Therapeutic indication
Treatment of hypotension in haemodynamically unstable neonates, infants and children < 18 years
MeSH:
Hypotension
Group:
Cardiac therapy
Active substances
dopamine hydrochloride
Dopamine
Marketing Authorisation Holder
BrePco Biopharma Limited
MAH
Timeline
Filter by authority:
EMA
Neoatricon authorised
27 May 2024
authorised
regulatory
Neoatricon | uMedical